Drug Science response to ACMD call for evidence on cannabis-based products for medicinal use
Drug Science has responded to the Advisory Council on the Misuse of Drug’s (ACMD’s) call for evidence related to cannabis-based products for medicinal use (CBPMs). We hope that our evidence will inform future policy decisions, develop rational debate, and support further research into these compounds.
